Track topics on Twitter Track topics that are important to you
The post Northwest Bio’s DCVax-L: is the hype warranted for glioblastoma patients? appeared first on Pharmaceutical Technology.NEXT ARTICLE
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain tumours are gliomas, a broad term which includes all tum...